Alyeska Investment Group
HCAQ

Alyeska Investment Group’s HealthCor Catalio Acquisition Corp. Class A Ordinary Shares HCAQ Stock Holding History

Alyeska Investment Group’s Portfolio HCAQ Stock Details HCAQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-350,000
Closed -$3.46M – 802
2021
Q3 		$3.46M Hold
350,000
– – 0.04% 399
2021
Q2 		$3.45M Hold
350,000
– – 0.04% 415
2021
Q1 		$3.5M Buy
+350,000
New +$3.59M 0.05% 383

Alyeska Investment Group's HCAQ Position: Q4 2021 in Review

Alyeska Investment Group sold out of HealthCor Catalio Acquisition Corp. Class A Ordinary Shares (HCAQ) in Q4 2021, closing a stake of 350,000 shares — an estimated $3.46M sold.

Alyeska Investment Group first reported a position in HCAQ in Q1 2021 and held it in 3 quarters. The position peaked at $3.5M in Q1 2021. 0 funds tracked by Wall St. Rank hold HCAQ as of Q4 2021.

  • Alyeska Investment Group reported no remaining HealthCor Catalio Acquisition Corp. Class A Ordinary Shares position as of Q4 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 350,000 HealthCor Catalio Acquisition Corp. Class A Ordinary Shares shares in Q4 2021, an estimated $3.46M.
  • Alyeska Investment Group first reported a position in HealthCor Catalio Acquisition Corp. Class A Ordinary Shares in Q1 2021 and held it in 3 quarters.
  • Alyeska Investment Group's HealthCor Catalio Acquisition Corp. Class A Ordinary Shares position peaked at $3.5M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held HealthCor Catalio Acquisition Corp. Class A Ordinary Shares as of Q4 2021.

Based on Alyeska Investment Group's 13F filing for Q4 2021, filed 14 Feb 2022.